Romano Brothers And Company Eli Lilly & CO Transaction History

Romano Brothers And Company

$757 Million
Q1 2025

A detailed history of Romano Brothers And Company transactions in Eli Lilly & CO stock. As of the latest transaction made, Romano Brothers And Company holds 6,050 shares of LLY stock, worth $4.97 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

6,050

Previous 5,519 9.62%

Holding current value

$4.97 Million

Previous $4.26 Million 17.28%

% of portfolio

0.66%

Previous 0.55%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$725.72 - $929.72 $385,357 - $493,681	531 Added 9.62%	6,050 $5 Million
Q4 2024 Jan 15, 2025	SELL	$727.2 - $932.06 $5,090 - $6,524	-7 Reduced 0.13%	5,519 $4.26 Million
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $28,569 - $35,520	37 Added 0.67%	5,526 $4.9 Million
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $21,021 - $26,362	29 Added 0.53%	5,489 $4.97 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $155,748 - $208,369	-263 Reduced 4.6%	5,460 $4.25 Million
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $3.01 Million - $3.54 Million	5,723 New	5,723 $3.34 Million
Q3 2023 Oct 17, 2023	BUY	$434.7 - $599.3 $2.63 Million - $3.63 Million	6,053 New	6,053 $3.25 Million
Q2 2023 Jul 12, 2023	BUY	$350.74 - $468.98 $22,798 - $30,483	65 Added 1.11%	5,941 $2.79 Million
Q1 2023 Apr 13, 2023	BUY	$310.63 - $364.82 $452,277 - $531,177	1,456 Added 32.94%	5,876 $2.02 Million
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $321,550 - $374,670	-1,000 Reduced 18.45%	4,420 $0
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $1.61 Million - $1.83 Million	5,420 New	5,420 $1.75 Million

Others Institutions Holding LLY

# of Institutions

4,375

Shares Held

758M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $781B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Romano Brothers And Company, based on Form 13F filings with the SEC.

News

Stay updated on Romano Brothers And Company with notifications on news.

Account

Romano Brothers And Company Eli Lilly & CO Transaction History